I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 5 studies | 25% ± 7% | |
| glutamatergic neuron | 3 studies | 30% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 5 studies | 25% ± 7% | |
| glutamatergic neuron | 3 studies | 30% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 23% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 874.55 | 1444 / 1445 | 100% | 15.50 | 183 / 183 |
| lung | 100% | 1088.40 | 576 / 578 | 100% | 13.90 | 1152 / 1155 |
| breast | 100% | 1027.08 | 459 / 459 | 99% | 15.57 | 1105 / 1118 |
| prostate | 100% | 1183.73 | 245 / 245 | 98% | 8.37 | 494 / 502 |
| brain | 99% | 742.86 | 2609 / 2642 | 99% | 15.07 | 701 / 705 |
| pancreas | 100% | 827.33 | 328 / 328 | 98% | 12.91 | 174 / 178 |
| bladder | 100% | 1131.05 | 21 / 21 | 97% | 11.29 | 491 / 504 |
| uterus | 100% | 1367.35 | 170 / 170 | 97% | 12.97 | 447 / 459 |
| skin | 99% | 1610.99 | 1799 / 1809 | 97% | 24.87 | 458 / 472 |
| intestine | 100% | 1037.01 | 965 / 966 | 97% | 8.84 | 509 / 527 |
| stomach | 100% | 814.07 | 359 / 359 | 95% | 9.07 | 272 / 286 |
| adrenal gland | 100% | 998.78 | 258 / 258 | 93% | 8.55 | 215 / 230 |
| kidney | 100% | 620.47 | 89 / 89 | 93% | 8.78 | 842 / 901 |
| thymus | 100% | 803.55 | 652 / 653 | 89% | 5.51 | 538 / 605 |
| ovary | 100% | 925.33 | 180 / 180 | 85% | 6.35 | 367 / 430 |
| liver | 94% | 411.67 | 212 / 226 | 58% | 3.54 | 235 / 406 |
| spleen | 100% | 603.81 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.82 | 1 / 1 |
| blood vessel | 100% | 1306.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 945.31 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 97% | 804.91 | 838 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 9.59 | 43 / 45 |
| muscle | 77% | 232.31 | 617 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 61% | 3.90 | 49 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 2.61 | 15 / 29 |
| peripheral blood | 24% | 231.66 | 220 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FKBP14 |
| Protein name | Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase) FKBP prolyl isomerase 14 peptidylprolyl isomerase (EC 5.2.1.8) |
| Synonyms | hCG_38314 FKBP22 UNQ322/PRO381 tcag7.681 |
| Description | FUNCTION: PPIase which accelerates the folding of proteins during protein synthesis. Has a preference for substrates containing 4-hydroxylproline modifications, including type III collagen. May also target type VI and type X collagens. . |
| Accessions | ENST00000222803.10 A0A090N7V8 Q9NWM8 ENST00000419018.1 F8WBZ0 ENST00000412494.1 H7C1Z9 |
